Issues related to prescription drug competition and pricing.
2025 · 1st Quarter (Jan 1 - Mar 31)
PATIENTS FOR AFFORDABLE DRUGS NOW
Filed by MCDERMOTT+ LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 2, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- MCDERMOTT+ LLC
- Filing UUID
- 901246cc-4a77-4d5e-af3a-0c0fd9c45b76
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.